Literature DB >> 25473336

Antioxidant and anti-inflammatory effects of Marrubium alysson extracts in high cholesterol-fed rabbits.

Soha S Essawy1, Dina M Abo-Elmatty2, Nabila M Ghazy3, Jihan M Badr4, Olov Sterner5.   

Abstract

The antioxidant and anti-inflammatory effects of hexane (HEXA), chloroform (CHLORO), ethyl acetate (EA) and total alcoholic (T. ALCOH) extracts of Marrubium alysson in hypercholesterolemic-fed rabbits were evaluated. Hypercholesterolemia was induced in male rabbits by high cholesterol diet (HCD) (350 mg/kg) for 8 weeks. Hypercholesterolemic rabbits were allocated into groups, treated with simvastatin (SIM 5 mg/kg), different extracts of M. alysson at two doses of 250, 500 mg/kg. A normal control group and an HCD control one were used for comparison. Lipid profile, as well as oxidized low density lipoprotein-cholesterol (ox-LDL-C), myeloperoxidase activity (MPO) and superoxide anion production (O2•(-)), C-reactive protein (CRP) and monocyte chemoattractant protein-1 (MCP-1) were also evaluated. In addition, histological examination of ascending aorta was performed. We found dyslipidemia associated with significant increases in ox-LDL-C 123.5 ± 9.8 nmol MDA/mg non-HDL, MPO activity 0.08 ± 0.05 U/100 mg tissue and O2•(-) production 3.5 ± 0.3 nmol cytochrome C reduced/min/g tissue × 10(-4) in hypercholerterolemic rabbits. In addition, there was a significant increase in CRP 6.6 ± 0.49 μmol/L and MCP-1 190.9 ± 6.4 pg/ml and its mRNA expression in HCD. Intima appeared thick with thick plaques surrounding the intima and luminal narrowing. SIM, EA and HEXA extracts of M. alysson had lipid lowering effect, decrease in ox-LDL-C, MPO, O2•(-), CRP and MCP-1 mRNA expression with improvement of the pathological picture. M. alysson enhanced the stability of plaque, had lipid lowering, anti-inflammatory and antioxidant activities.

Entities:  

Keywords:  Anti-inflammatory; Antioxidant; Hypercholesterolemia; Marrubium alysson

Year:  2013        PMID: 25473336      PMCID: PMC4246394          DOI: 10.1016/j.jsps.2013.12.004

Source DB:  PubMed          Journal:  Saudi Pharm J        ISSN: 1319-0164            Impact factor:   4.330


  39 in total

1.  Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.

Authors:  M A Albert; E Danielson; N Rifai; P M Ridker
Journal:  JAMA       Date:  2001-07-04       Impact factor: 56.272

Review 2.  The oxidative modification hypothesis of atherosclerosis: does it hold for humans?

Authors:  J L Witztum; D Steinberg
Journal:  Trends Cardiovasc Med       Date:  2001 Apr-May       Impact factor: 6.677

3.  Gastroprotective activity of methanol extract and marrubiin obtained from leaves of Marrubium vulgare L. (Lamiaceae).

Authors:  Ana Paula de Oliveira; José Roberto Santin; Marivane Lemos; Luiz Carlos Klein Júnior; Angélica Garcia Couto; Christiane Meyre da Silva Bittencourt; Valdir Cechinel Filho; Sérgio Faloni de Andrade
Journal:  J Pharm Pharmacol       Date:  2011-07-07       Impact factor: 3.765

4.  Chronic vascular inflammation in patients with type 2 diabetes: endothelial biopsy and RT-PCR analysis.

Authors:  Lei Feng; Carolyn Matsumoto; Allan Schwartz; Ann Marie Schmidt; David M Stern; John Pile-Spellman
Journal:  Diabetes Care       Date:  2005-02       Impact factor: 19.112

5.  The 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor pravastatin reduces disease activity and inflammation in dextran-sulfate induced colitis.

Authors:  Makoto Sasaki; Sulaiman Bharwani; Paul Jordan; Takashi Joh; Kenneth Manas; April Warren; Hirohisa Harada; Patsy Carter; John W Elrod; Michael Wolcott; Matthew B Grisham; J Steven Alexander
Journal:  J Pharmacol Exp Ther       Date:  2003-04       Impact factor: 4.030

6.  Transient increase in plasma oxidized LDL during the progression of atherosclerosis in apolipoprotein E knockout mice.

Authors:  Rina Kato; Chihiro Mori; Keiko Kitazato; Satoru Arata; Takashi Obama; Masahiro Mori; Katsuhiko Takahashi; Toshihiro Aiuchi; Tatsuya Takano; Hiroyuki Itabe
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-11-06       Impact factor: 8.311

7.  Cadmium-induced production of superoxide anion and nitric oxide, DNA single strand breaks and lactate dehydrogenase leakage in J774A.1 cell cultures.

Authors:  E A Hassoun; S J Stohs
Journal:  Toxicology       Date:  1996-09-02       Impact factor: 4.221

8.  EP2306 [2-(4-biphenyl)-4-methyl-octahydro-1,4-benzoxazin-2-ol, hydrobromide], a novel squalene synthase inhibitor, reduces atherosclerosis in the cholesterol-fed rabbit.

Authors:  Anna Tavridou; Loukas Kaklamanis; Apostolos Papalois; Angeliki P Kourounakis; Eleni A Rekka; Panos N Kourounakis; Avgui Charalambous; Vangelis G Manolopoulos
Journal:  J Pharmacol Exp Ther       Date:  2007-09-05       Impact factor: 4.030

9.  Phenylpropanoid glycosides from Marrubium alysson.

Authors:  I Caliş; M Hosny; T Khalifa; P Rüedi
Journal:  Phytochemistry       Date:  1992-10       Impact factor: 4.072

10.  A comparative study of the in vitro antioxidant activity of statins.

Authors:  Ferdinando Franzoni; Alfredo Quiñones-Galvan; Francesco Regoli; Ele Ferrannini; Fabio Galetta
Journal:  Int J Cardiol       Date:  2003-08       Impact factor: 4.164

View more
  2 in total

1.  Marrubium alysson L. Ameliorated Methotrexate-Induced Testicular Damage in Mice through Regulation of Apoptosis and miRNA-29a Expression: LC-MS/MS Metabolic Profiling.

Authors:  Reda F A Abdelhameed; Asmaa I Ali; Sameh S Elhady; Hend E Abo Mansour; Eman T Mehanna; Sarah M Mosaad; Salma A Ibrahim; Rawan H Hareeri; Jihan M Badr; Nermeen A Eltahawy
Journal:  Plants (Basel)       Date:  2022-09-03

2.  Biochemical profile and in vitro biological activities of extracts from seven folk medicinal plants growing wild in southern Tunisia.

Authors:  Hajer Tlili; Najjaa Hanen; Abdelkerim Ben Arfa; Mohamed Neffati; Abdelbasset Boubakri; Daniela Buonocore; Maurizia Dossena; Manuela Verri; Enrico Doria
Journal:  PLoS One       Date:  2019-09-17       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.